<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02006394</url>
  </required_header>
  <id_info>
    <org_study_id>IRB #110549</org_study_id>
    <nct_id>NCT02006394</nct_id>
  </id_info>
  <brief_title>Novel Dietary Interventions for Treating Insulin Resistance</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Diego</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Diego</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Clinical and rodent studies have demonstrated the impact of specific dietary factors in
      modulating inflammation-related diseases including insulin resistance, type 2 diabetes, and
      cardiovascular disease. Such dietary factors include polyunsaturated fats, polyphenols, and
      glycemic index. The investigators know from previous studies in the literature that reducing
      the glycemic index and increasing the omega-3 fat and polyphenol content of the diet results
      in improved metabolic indices and reduced inflammation. These improvements can be observed
      even within the context of persistent obesity. The investigators will implement a
      reduced-calorie, multi-pronged dietary approach for improving insulin sensitivity and
      reducing inflammation in obese subjects with the metabolic syndrome. The active diet will
      include reduced glycemic index foods together with omega-3 fats and polyphenol supplements.
      The primary hypothesis is that the dietary combination of reduced glycemic index foods,
      omega-3 fats and polyphenols will work to reduce insulin resistance and inflammation more
      efficiently than a placebo-controlled, calorie- and macronutrient-matched diet in obese
      subjects with the metabolic syndrome.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">November 2013</completion_date>
  <primary_completion_date type="Actual">July 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in insulin resistance</measure>
    <time_frame>Baseline, 6 weeks, and 12 weeks</time_frame>
    <description>Fasting plasma insulin, Homeostasis Model of Assessment - Insulin Resistance (HOMA-IR)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in inflammation biomarkers</measure>
    <time_frame>Baseline, 6 weeks, 12 weeks</time_frame>
    <description>Fasting plasma cytokines and C-reactive protein (CRP), monocyte expression of inflammatory genes</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in adipokines</measure>
    <time_frame>Baseline, 6 weeks, 12 weeks</time_frame>
    <description>Fasting plasma adiponectin and leptin</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">41</enrollment>
  <condition>Insulin Resistance</condition>
  <condition>Obesity</condition>
  <condition>Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>Active Diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Reduced glycemic index bread products, fish oil capsules, and polyphenol capsules.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Diet</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Market variety bread products, corn oil capsules, and corn starch capsules.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Fish Oil</intervention_name>
    <description>fish oil capsules</description>
    <arm_group_label>Active Diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Polyphenol Capsules</intervention_name>
    <description>delphinidin polyphenol capsules</description>
    <arm_group_label>Active Diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Corn Oil Capsules</intervention_name>
    <description>Corn Oil Capsules</description>
    <arm_group_label>Placebo Diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Corn starch capsules</intervention_name>
    <description>Maltodextrin capsules</description>
    <arm_group_label>Placebo Diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Reduced glycemic index bread products</intervention_name>
    <description>Made by Zone Labs</description>
    <arm_group_label>Active Diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Market variety bread products</intervention_name>
    <description>placebo bread products</description>
    <arm_group_label>Placebo Diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Body Mass Index (BMI): 30.0-40.9 kg/m^2

          -  Metabolic Syndrome

        Exclusion Criteria:

          -  Diabetes

          -  Inflammatory diseases

          -  Eating disorders

          -  Pregnancy

          -  Known kidney, coronary, gastrointestinal or peripheral artery disease

          -  Smoking

          -  Recent fish oil (&gt;500mg eicosapentaenoic acid (EPA) + docosahexaenoic acid (DHA)/day)
             or polyphenol supplement use

          -  Recent weight change

          -  Strenuous exercise

          -  Fish/food allergies

          -  Current diabetic, lipid-lowering (fibrates, statins), anti-inflammatory,
             immune-suppressant, and/or anti-inflammatory hypertension medication use
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dorothy Sears, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Diego</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California, San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92093</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 4, 2013</study_first_submitted>
  <study_first_submitted_qc>December 4, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 10, 2013</study_first_posted>
  <last_update_submitted>December 10, 2013</last_update_submitted>
  <last_update_submitted_qc>December 10, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 12, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Diego</investigator_affiliation>
    <investigator_full_name>Dorothy Sears</investigator_full_name>
    <investigator_title>Associate Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Inflammation</keyword>
  <keyword>Monocytes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Syndrome X</mesh_term>
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

